Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DB25FHZ62
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,364
Award facts
- Contract value 100% obligated
- $33,364.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL medication. This is a firm fixed-price delivery order valued at $33,364.14, with an ultimate completion date of July 22, 2025. The award carries no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems through its comprehensive pharmaceutical supply agreements with the Defense Logistics Agency. The company's portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This specific delivery order for HUMIRA, a prescription immunosuppressant commonly used to treat rheumatoid arthritis and other autoimmune conditions, represents a routine fulfillment under the DLA's pharmaceutical prime vendor program, which supports Defense Health Agency requirements and other federal healthcare systems globally.
Quick answers
Who was awarded contract SPE2DB25FHZ62?
SPE2DB25FHZ62 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FHZ62 worth?
The government has obligated $33,364 on SPE2DB25FHZ62.
Is contract SPE2DB25FHZ62 an order under another contract?
Yes. SPE2DB25FHZ62 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FHZ62 competed?
The extent of competition for SPE2DB25FHZ62 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award